A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Keywords: Multiple myeloma; Stem cell transplantation; Transplantation conditioning; Preparative regimen; Melphalan; Propylene glycol-free melphalan; Captisol-enabled melphalan formulation